Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,785
datasets available to search
ShareScore release 0.9.0
Dataset results
2,785 results for “genotyping”
Efficacy and Safety of Alisporivir Triple Therapy in Chronic Hepatitis C Genotype 1 Treatment-naïve Participants
ClinicalTrials.gov study NCT01318694. IPD Sharing: Not stated. Countries: 21. Publications: 0.
Prevalence of Porphyromonas Gingivalis Fimbrial Subunit Genotype in Smokers and Nonsmokers After Periodontal Therapy
ClinicalTrials.gov study NCT02879903. IPD Sharing: YES. Countries: 0. Publications: 4.
Efficacy and Safety of Sofosbuvir Plus Ribavirin in Japanese Adults With Chronic Genotype 2 HCV Infection
ClinicalTrials.gov study NCT01910636. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ledipasvir/Sofosbuvir Fixed-Dose Combination and Vedroprevir With or Without Ribavirin in Treatment-Experienced Participants With Chronic Genotype 1 HCV Infection and Cirrhosis
ClinicalTrials.gov study NCT02226549. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase I/II Study of Combination of Sorafenib, Vorinostat, and Bortezomib for the Treatment of Acute Myeloid Leukemia With Complex- or Poor-risk (Monosomy 5/7) Cytogenetics or FLT3-ITD Positive Genotyp
ClinicalTrials.gov study NCT01534260. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Participants With Chronic Genotype 2 HCV Infection
ClinicalTrials.gov study NCT02738333. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of Induction Dosing With Peginterferon Alfa-2a and Ribavirin in Participants With Chronic Hepatitis C (CHC) Genotype 1 Infection
ClinicalTrials.gov study NCT00192647. IPD Sharing: Not stated. Countries: 6. Publications: 0.
The Assesment of MMP-1 Genotypes Polymorphism as a Risk Factor for HCC in Chronic HCV Patients With LC
ClinicalTrials.gov study NCT03722628. IPD Sharing: UNDECIDED. Countries: 0. Publications: 2.
Trichomonas Vaginalis Genotyping in Upper Egypt
ClinicalTrials.gov study NCT03614286. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Safety and Efficacy Study of the Combination Daclatasvir (60 mg), Sofosbuvir (400 mg) and Ribavirin (Weight-based Dosing) for 12 or 16 Weeks in Subjects With Genotype 3 Chronic HCV Infection With or W
ClinicalTrials.gov study NCT02319031. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Alisporivir With RBV in Chronic Hepatitis C Genotype 2 and 3 Participants for Whom Interferon is Not an Option
ClinicalTrials.gov study NCT02094443. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Determining the Sustained Virologic Response of Declatasvir in Egyptian Patients With Hepatitis C Virus Genotype 4
ClinicalTrials.gov study NCT02772744. IPD Sharing: UNDECIDED. Countries: 0. Publications: 3.
Human Papillomavirus Infection and Virus Genotyping in Uterine Cervix Cancer in Venezuela
ClinicalTrials.gov study NCT00937547. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3)
ClinicalTrials.gov study NCT01358864. IPD Sharing: Not stated. Countries: 12. Publications: 0.
Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 or 24 Weeks in Participants With Chronic Genotype 1 or 2 Hepatitis C Virus Infection Who Have Previously Failed a Direct-Acting Antiv
ClinicalTrials.gov study NCT02822794. IPD Sharing: YES. Countries: 1. Publications: 0.
A Phase 3 Study of a Daclatasvir/Asunaprevir/BMS-791325 Fixed Dose Combination (FDC) in Subjects With Chronic Hepatitis C Genotype 1
ClinicalTrials.gov study NCT02170727. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Genotype 1 Chronic Hepatitis C Virus Infection and Cirrhosis
ClinicalTrials.gov study NCT02114151. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study Evaluating Slow Response/Non-Rapid Response in Patients With Chronic Hepatitis C, Genotype 1, 2, 3 & 4 Treated With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)
ClinicalTrials.gov study NCT01429792. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Alisporivir (Deb025) and Boceprevir Triple Therapies in African American Participants Not Previously Treated for Chronic Hepatitis C Genotype 1
ClinicalTrials.gov study NCT01446250. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Genotype-guided Versus Standard for Warfarin Dosing
ClinicalTrials.gov study NCT03479684. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.